Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-24-132525
Filing Date
2024-12-30
Accepted
2024-12-30 16:46:44
Documents
1
Effectiveness Date
2024-12-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10062
  Complete submission text file 0001104659-24-132525.txt   11543
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-533696 | Film No.: 241590356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)